CROSS HERB 4
4 · Jasper Therapeutics, Inc. · Filed Sep 26, 2023
Insider Transaction Report
Form 4
CROSS HERB
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-09-22+550,000→ 550,000 totalExercise: $0.78Exp: 2033-09-22→ Voting Common Stock (550,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on September 22, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.